Repligen Corp. (RGEN)
115.16
+0.84
(+0.73%)
USD |
NASDAQ |
Mar 26, 12:06
Repligen Cash from Investing (Quarterly) : -208.74M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Masimo Corp. | -8.70M |
| Orthofix Medical, Inc. | -10.86M |
| InfuSystem Holdings, Inc. | -2.192M |
| Tandem Diabetes Care, Inc. | -14.98M |
| Plus Therapeutics, Inc. | -1.077M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 25.70M |
| Cash from Financing (Quarterly) | 0.195M |
| Free Cash Flow | 91.69M |
| Free Cash Flow Per Share (Quarterly) | 0.307 |
| Free Cash Flow to Equity (Quarterly) | 16.31M |
| Free Cash Flow to Firm (Quarterly) | 21.50M |
| Free Cash Flow Yield | 1.41% |